Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wellgistics Health (WGRX) Cash from Financing Activities (2024 - 2025)

Wellgistics Health's Cash from Financing Activities history spans 2 years, with the latest figure at $2.4 million for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities rose 14.89% year-over-year to $2.4 million, compared with a TTM value of $10.8 million through Dec 2025, up 503.0%, and an annual FY2025 reading of $10.8 million, up 503.0% over the prior year.
  • Cash from Financing Activities for Q4 2025 was $2.4 million at Wellgistics Health, down from $5.2 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $5.2 million in Q3 2025, with the low at -$538037.0 in Q2 2024.